All < Article List - KBR

Curocell receives government funding to expand CAR-T treatment into lupus

Curocell, a local chimeric antigen receptor-T (CAR-T) developer, said it will start developing a next-generation Anti-CD19 CAR-T therapy for treatment-resistant systemic lupus erythematosus (SLE) as part of the2024 Multi-Ministerial Regenerative Medicine Technology Development Program.This initiativ
Pharma Lee Han-soo 2024.04.09 12:51
Hugel’s PDO suture brand Licellvi gets marketing authorization in Brazil

Hugel, a total medical aesthetics company, said Tuesday that its polydioxanone (PDO) suture brand Licellvi (domestic product name: Blue Rose Forte) has received a product license from the Brazilian National Agency for Food and Drug Surveillance (ANVISA).Licellvi is a PDO suture brand of JWorld, a su
Pharma Korea Biomedical Review 2024.04.09 11:46
Bam Yang Gang craze in health supplements: portable, convenient formulations lead the way

An increasing number of health supplements are differentiating themselves from traditional forms, such as capsules and pills, to various formulations, attempting to attract consumers with formulations that focus on portability and convenience of consumption.CJ ENM's digital marketing affiliate, Mezz
Pharma Yang Hyeon-su 2024.04.09 11:38
Early onset of hot flashes, night sweats in menopausal women linked to higher risk of depression: study

Menopausal women who experienced an early onset of vasomotor symptoms (VMSs), commonly known as hot flashes and night sweats, are at a higher risk of developing depressive symptoms, according to a study by Korean researchers.Professors Ryu Seung-ho, Chang Yoo-soo, and Dr. Choi Hye-rin at the Center
Hospital Kim Yoon-mi 2024.04.09 10:30
Daewoong seeks permit for Korea's 1st homegrown SGLT2 diabetes drug Envlo in Mexico

Daewoong Pharmaceutical said that it applied for product approval for Envlo, the first homegrown sodium-glucose cotransporter 2 (SGLT2) diabetes drug in Korea and the nation's 36th newly developed drug, to Mexico's Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS).COFEPRIS is
Pharma Lee Han-soo 2024.04.08 17:16
ViGenCell begins enrolling patients for P1 trial of AML drug

ViGenCell said Monday that it had initiated the Cohort 3 study, the final step of the phase 1 clinical trial of VT-Tri(1)-A for treating acute myeloid leukemia (AML).VT-Tri(1)-A is ViGenCell's first-in-class treatment for AML. It targets multiple common antigens. Last September, it began enrolling p
Bio Kim Kyoung-Won 2024.04.08 16:33
KRX suspends EDGC trading due to audit result controversy

The Korea Exchange (KRX) has suspended stock trading of EONE-Diagnomics Genome Center (EDGC), a Kosdaq-listed genomic analysis company, due to unverified rumors that the company received a disclaimer of opinion during its audit process.The suspension took effect when the market opened Monday, with K
Device/ICT Lee Han-soo 2024.04.08 16:21
Celltrion secures major PBM contract for Zymfentra in the US

Celltrion said it has completed a registration contract for its subcutaneous (SC) Remicade biosimilar, Zymfentra (infliximab), with one of the top three pharmaceutical benefit managers (PBMs) in the United States."We are pleased to announce through our website that we have successfully closed a deal
Pharma Kim Chan-hyuk 2024.04.08 16:02
Government to review proposal to postpone med student increase for 1 year: vice minister

The government said Monday that it would conduct an internal review of the Korean Medical Association (KMA)'s emergency committee's proposal to re-discuss increasing the number of medical students after a one-year moratorium.The government also said that although the enrollment quota has been alloca
Policy Kwak Sung-sun 2024.04.08 15:24
[Photo News] UK Health Security Agency Chief Executive visits Seegene headquarters in Seoul

Seegene, a Korean in vitro diagnostics company, recently hosted Jenny Harries, Chief Executive of the UK Health Security Agency (UKHSA), at its headquarters in Songpa-gu, Seoul.The visit, which took place on March 27, served as a platform for both parties to discuss innovative strategies to create a
Device/ICT Lee Han-soo 2024.04.08 14:30
Lunit AI software proves early breast cancer detection, reduced workload for radiologists

Lunit said it published a study showing that using Lunit Insight MMG, its AI image analysis solution for mammography, can increase the likelihood of early breast cancer diagnosis and significantly reduce the workload of physicians.The study, conducted in collaboration with researchers from various u
Device/ICT Lee Han-soo 2024.04.08 14:06
Pinotbio releases preclinical results of new drug and linker at AACR 2024

Pinotbio is increasing its competitiveness on the global stage by emphasizing effectiveness and safety by combining the “PBX-7 Series” and “sequential cleavage linker.”Pinotbio, an ADC platform company, said Monday that it unveiled preclinical results of its ADC platform at the American Association
Bio Korea Biomedical Review 2024.04.08 14:00
'Japanese model of med school enrollment, regional quota system might be a lesson for Korea'

As the government and the medical community debate the increase in medical school enrollment quota, it has been suggested that Korea should learn from Japan, which increased medical school students and operates a regional quota system to solve the problem of regional medical disparities ahead of Kor
Policy Kim Eun-young 2024.04.08 13:38
Korean patients seek WHO intervention amid healthcare standoff

As the healthcare void continues due to a standoff between the government and the medical community over the increasing number of medical students, a patient group said it would ask the World Health Organization (WHO) to intervene in the ongoing medical crisis in Korea.The Korea Severe Disease Assoc
People Kim Ju-yeon 2024.04.08 13:19
Korean and foreign experts jointly tackle threats of pancreatic and biliary disease

Amid a growing consensus that domestic and international medical practitioners should collaborate to find solutions to the growing risk of pancreatic and biliary tract diseases, some experts stressed the need for active state support for research investment to develop treatments and diagnostics.The
Hospital Kim Chan-hyuk 2024.04.08 11:26
EuBiologics opens new office in Boston's Cambridge Innovation Center to accelerate global vaccine development

EuBiologics, a Korean vaccine maker targeting the global public health market, said it opened a new office at the Cambridge Innovation Center (CIC) in Boston, one of the largest biotech clusters in the world.EuBiologics' new office opening comes after their selection by KHIDI (Korea Health Industry
Pharma Lee Han-soo 2024.04.08 10:56
Severance Hospital's study validates efficacy of stereotactic ablative radiotherapy for limited metastatic cancer cases

A team at Severance Hospital found that stereotactic ablative radiotherapy (SABR) was effective in treating patients with limited metastatic liver cancer.Limited metastatic cancer is defined by the early stage of cancer spread, where metastasis is confined to five or fewer organs.This condition nece
Hospital Lee Han-soo 2024.04.05 17:06
Why are there radiotherapy limits for neuroendocrine tumors if there aren't any for thyroid cancer?

As the benefits of treating cancer with "radioactive" substances that emit radiation, such as alpha, beta, gamma, X-ray, and positron rays, have become established, radiopharmaceutical cancer therapy, which has been introduced for thyroid cancer, pediatric neuroblastoma, and neuroendocrine tumors, i
Hospital Kim Kyoung-Won 2024.04.05 16:39
Hanmi Science appoints youngest son as new Co-CEO

In a move signaling a potential resolution to ongoing family disputes, Hanmi Science, the holding company of Hanmi Pharm, announced the appointment of Lim Jong-hoon as co-CEO alongside the current chairperson, Song Young-sook.The decision came during a board meeting held at Hanmi headquarters in Son
Pharma Lee Han-soo 2024.04.05 15:52
Celltrion partners with the Crohn's & Colitis Foundation to enhance IBD awareness in US

Celltrion has embarked on a partnership with the Crohn's & Colitis Foundation (CCF), the largest patient advocacy group for inflammatory bowel disease (IBD) in the U.S., aiming to boost awareness and improve perceptions of IBD, a chronic inflammatory condition of the gastrointestinal tract.The CCF,
Bio Lee Han-soo 2024.04.05 15:09